Tiger, BICO is one of the few "biotech?" companies I love to hate.|
I don't consider them I Biotech and I won't go into detail on my
opinions. However, their preparation for their last FDA was "poor"
at best (they presented data on an out-dated machine that frequently
didn't work and produced "believable" data on a small percentage of
patients generated under laboratory conditions). About the only good
thing I can say about them is their ability to bring their share price
below $1 which I predicted when they made their last FDA presentation.
I have no BICO position although I occasionally remind investors that
BICO certainly doesn't behave like research oriented Biotechs.